PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16105974-0	2005	NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia.	bafetinib	0-6	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	36-43	
16105974-3	2005	We have identified a specific dual Abl-Lyn inhibitor, NS-187 (elsewhere described as CNS-9), which is 25 to 55 times more potent than imatinib in vitro.	bafetinib	54-60	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	35-38